We are live on ! Find out more
NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.16%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
10 Year Est. Return
AUM
$705M
AUM Growth
-$33.5M
Cap. Flow
-$127M
Cap. Flow %
-18%
Top 10 Hldgs %
65.12%
Holding
53
New
9
Increased
1
Reduced
9
Closed
5

Sector Composition

1 Communication Services 25.87%
2 Consumer Discretionary 15.73%
3 Healthcare 12.78%
4 Technology 10.72%
5 Financials 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$276B
$99.2M 14.07%
704,382
BAC icon
2
Bank of America
BAC
$430B
$58.2M 8.24%
2,396,982
-220,000
-8% -$5.13M
AAPL icon
3
Apple
AAPL
$4.9T
$49.2M 6.97%
1,365,588
-160,000
-10% -$5.92M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.23T
$47.8M 6.77%
1,028,000
-138,800
-12% -$6.49M
DIS icon
5
Walt Disney
DIS
$170B
$41.8M 5.92%
393,230
BIDU icon
6
Baidu
BIDU
$36.5B
$39.5M 5.59%
220,657
-45,813
-17% -$8.3M
META icon
7
Meta Platforms (Facebook)
META
$1.64T
$38.8M 5.51%
257,300
-40,500
-14% -$6.02M
IBB icon
8
iShares Biotechnology ETF
IBB
$9.23B
$26.8M 3.8%
259,050
-138,000
-35% -$13.6M
AGN
9
DELISTED
Allergan plc
AGN
$23.3M 3.3%
95,648
-12,500
-12% -$2.94M
XLV icon
10
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$23M 3.26%
290,100
XLE icon
11
State Street Energy Select Sector SPDR ETF
XLE
$38.2B
$16.3M 2.31%
502,560
OLED icon
12
Universal Display
OLED
$3.75B
$11.8M 1.67%
107,889
JD icon
13
JD.com
JD
$40B
$11.2M 1.59%
286,335
-114,389
-29% -$4.32M
BMY icon
14
Bristol-Myers Squibb
BMY
$124B
$10.4M 1.47%
186,000
CELG
15
DELISTED
Celgene Corp
CELG
$9.21M 1.31%
70,917
MA icon
16
Mastercard
MA
$480B
$8.43M 1.19%
69,400
LMT icon
17
Lockheed Martin
LMT
$117B
$8.33M 1.18%
30,000
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.16M 1.16%
89,900
+34,000
+61% +$3.09M
LBTYA icon
19
Liberty Global Class A
LBTYA
$3.52B
$7.62M 1.08%
237,371
C icon
20
Citigroup
C
$217B
$6.82M 0.97%
101,930
BIIB icon
21
Biogen
BIIB
$30.4B
$6.51M 0.92%
24,000
GILD icon
22
Gilead Sciences
GILD
$167B
$6.16M 0.87%
86,959
ACAD icon
23
Acadia Pharmaceuticals
ACAD
$4.38B
$5.72M 0.81%
+205,000
New +$6.11M
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
$5.6M 0.79%
46,000
NXPI icon
25
NXP Semiconductors
NXPI
$67.3B
$5.1M 0.72%
+46,600
New +$4.99M

Similar funds

NF Trinity Capital's Q2 2017 Portfolio in Review

As of Q2 2017, NF Trinity Capital held 53 positions worth $705M, down 4.5% from $739M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

NF Trinity Capital withdrew a net $127M in Q2 2017, closing 5 positions and reducing 9 holdings. Its most notable exit was PayPal, an estimated $5.42M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, NF Trinity Capital opened a new position in Acadia Pharmaceuticals worth $5.72M.

  • NF Trinity Capital's largest Q2 2017 buy was Acadia Pharmaceuticals: 205,000 shares worth $5.72M.
  • NF Trinity Capital added most to BioMarin Pharmaceuticals in Q2 2017, an estimated $3.09M increase.
  • NF Trinity Capital's biggest Q2 2017 reduction was iShares Biotechnology ETF, cutting an estimated $13.6M.
  • NF Trinity Capital fully exited PayPal in Q2 2017, selling an estimated $5.42M.
  • NF Trinity Capital's ten largest holdings make up 65% of its $705M portfolio in Q2 2017.
  • NF Trinity Capital opened 9 new positions and closed 5 in Q2 2017.
  • NF Trinity Capital's portfolio value fell 4.5% quarter-over-quarter to $705M.

Based on NF Trinity Capital's 13F filing for Q2 2017, filed 8 Aug 2017.